These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32602096)

  • 21. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the Choice of the Extracellular Vesicles for Therapeutic Purposes.
    Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking.
    Murphy DE; de Jong OG; Brouwer M; Wood MJ; Lavieu G; Schiffelers RM; Vader P
    Exp Mol Med; 2019 Mar; 51(3):1-12. PubMed ID: 30872574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial Progenitor Cell-Derived Extracellular Vesicles: A Novel Candidate for Regenerative Medicine and Disease Treatment.
    Xing Z; Zhao C; Liu H; Fan Y
    Adv Healthc Mater; 2020 Jun; 9(12):e2000255. PubMed ID: 32378361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal and Induced Pluripotent Stem Cells-Derived Extracellular Vesicles: The New Frontier for Regenerative Medicine?
    Barreca MM; Cancemi P; Geraci F
    Cells; 2020 May; 9(5):. PubMed ID: 32397132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle-Mediated Delivery of miRNA.
    Shojaati G; Khandaker I; Funderburgh ML; Mann MM; Basu R; Stolz DB; Geary ML; Dos Santos A; Deng SX; Funderburgh JL
    Stem Cells Transl Med; 2019 Nov; 8(11):1192-1201. PubMed ID: 31290598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acellular approaches for regenerative medicine: on the verge of clinical trials with extracellular membrane vesicles?
    Fuster-Matanzo A; Gessler F; Leonardi T; Iraci N; Pluchino S
    Stem Cell Res Ther; 2015 Dec; 6():227. PubMed ID: 26631254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles.
    Zhang B; Yeo RW; Tan KH; Lim SK
    Int J Mol Sci; 2016 Feb; 17(2):174. PubMed ID: 26861305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Vesicle Therapeutics in Regenerative Medicine.
    Imafuku A; Sjoqvist S
    Adv Exp Med Biol; 2021; 1312():131-138. PubMed ID: 33330962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injectable hydrogels for sustained delivery of extracellular vesicles in cartilage regeneration.
    van de Looij SM; de Jong OG; Vermonden T; Lorenowicz MJ
    J Control Release; 2023 Mar; 355():685-708. PubMed ID: 36739906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-rich plasma-derived extracellular vesicles: A superior alternative in regenerative medicine?
    Wu J; Piao Y; Liu Q; Yang X
    Cell Prolif; 2021 Dec; 54(12):e13123. PubMed ID: 34609779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative Medicine.
    Ilahibaks NF; Lei Z; Mol EA; Deshantri AK; Jiang L; Schiffelers RM; Vader P; Sluijter JPG
    Cells; 2019 Nov; 8(12):. PubMed ID: 31775322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleic acid delivery with extracellular vesicles.
    Schulz-Siegmund M; Aigner A
    Adv Drug Deliv Rev; 2021 Jun; 173():89-111. PubMed ID: 33746014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery.
    van Dongen HM; Masoumi N; Witwer KW; Pegtel DM
    Microbiol Mol Biol Rev; 2016 Jun; 80(2):369-86. PubMed ID: 26935137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective Therapeutic Applications of Platelet Extracellular Vesicles.
    Johnson J; Wu YW; Blyth C; Lichtfuss G; Goubran H; Burnouf T
    Trends Biotechnol; 2021 Jun; 39(6):598-612. PubMed ID: 33160678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering approaches for effective therapeutic applications based on extracellular vesicles.
    Kwon S; Shin S; Do M; Oh BH; Song Y; Bui VD; Lee ES; Jo DG; Cho YW; Kim DH; Park JH
    J Control Release; 2021 Feb; 330():15-30. PubMed ID: 33278480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular vesicles as personalized medicine.
    Beetler DJ; Di Florio DN; Bruno KA; Ikezu T; March KL; Cooper LT; Wolfram J; Fairweather D
    Mol Aspects Med; 2023 Jun; 91():101155. PubMed ID: 36456416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.